RhumbLine Advisers’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Buy
29,583
+660
+2% +$6.26K ﹤0.01% 3088
2026
Q1
$248K Buy
28,923
+589
+2% +$5.28K ﹤0.01% 3022
2025
Q4
$250K Sell
28,334
-4,318
-13% -$49.9K ﹤0.01% 3069
2025
Q3
$433K Sell
32,652
-578
-2% -$7.23K ﹤0.01% 2787
2025
Q2
$454K Buy
33,230
+8,403
+34% +$113K ﹤0.01% 2742
2025
Q1
$341K Buy
24,827
+7,914
+47% +$115K ﹤0.01% 2816
2024
Q4
$289K Buy
16,913
+3,266
+24% +$56.6K ﹤0.01% 3010
2024
Q3
$251K Buy
+13,647
New +$241K ﹤0.01% 3120

Other funds holding ARDT

RhumbLine Advisers's ARDT Position: Q2 2026 in Review

RhumbLine Advisers increased its Ardent Health (ARDT) stake by 2.3% in Q2 2026, buying an estimated $6.26K and bringing the position to 29,583 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3088.

RhumbLine Advisers first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $454K in Q2 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • RhumbLine Advisers held 29,583 shares of Ardent Health worth $291K as of Q2 2026.
  • RhumbLine Advisers bought 660 Ardent Health shares in Q2 2026, an estimated $6.26K.
  • Ardent Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3088 holding.
  • RhumbLine Advisers first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • RhumbLine Advisers's Ardent Health position peaked at $454K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.